Cholesterol inhibition, cancer, and chemotherapy
- 1 May 1992
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 339 (8802), 1154-1156
- https://doi.org/10.1016/0140-6736(92)90744-n
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Effect of Partial Ileal Bypass Surgery on Mortality and Morbidity from Coronary Heart Disease in Patients with HypercholesterolemiaNew England Journal of Medicine, 1990
- CANCER MORTALITY AND LIPID AND LIPOPROTEIN LEVELSAmerican Journal of Epidemiology, 1990
- Regulation of the mevalonate pathwayNature, 1990
- Cancer Incidence and Cancer Mortality in Relation to Serum CholesterolJNCI Journal of the National Cancer Institute, 1989
- p21ras is modified by a farnesyl isoprenoid.Proceedings of the National Academy of Sciences, 1989
- Genetic and Pharmacological Suppression of Oncogenic Mutations in RAS Genes of Yeast and HumansScience, 1989
- Plasma cholesterol, coronary heart disease, and cancer in the Renfrew and Paisley survey.BMJ, 1989
- Plasma cholesterol and cancer morbidity and mortality in an adult communityJournal of Chronic Diseases, 1984
- RISK OF CANCER AND DEATH IN RELATION TO SERUM CHOLESTEROLAmerican Journal of Epidemiology, 1982
- PLASMA LIPIDS AND MORTALITY: A SOURCE OF ERRORThe Lancet, 1980